Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options
 Helius Minerals Ltd HHH 24. avr 2025 0.60 0.00   
 Helix Biopharma HBP 24. avr 2025 0.78 0.00   
 Hemisphere Energy Corp HME 24. avr 2025 1.72 -1.15   
 Hemostemix Inc HEM 24. avr 2025 0.10 0.00   
 Hempalta Corp. HEMP 24. avr 2025 0.06 0.00   
 Hercules Metals Corp. BIG 24. avr 2025 0.62 +5.08   
 Heroux-Devtek Inc. HRX 24. avr 2025 32.48 0.00   
 High Arctic Energy Services Inc HWO 24. avr 2025 0.80 0.00   
 High Arctic Overseas Holdings Corp. HOH 24. avr 2025 0.98 0.00   
 High Liner Foods Inc HLF 24. avr 2025 16.68 -0.77   
 High Mountain 2 Capital Corporation HMCC.P 24. avr 2025 0.05 0.00   
 High Tide HITI 24. avr 2025 3.30 +1.23   
 Highbank Resources Ltd. HBK 24. avr 2025 0.02 0.00   
 Highland Copper Company Inc HI 24. avr 2025 0.10 -13.64   
 Highway 50 Gold HWY 24. avr 2025 0.34 0.00   
 Highwood Asset Management Ltd HAM 24. avr 2025 5.40 0.00   
 Hill Incorporated HILL 24. avr 2025 0.20 0.00   
 Hispania Resources Inc ESPN 24. avr 2025 0.03 0.00   
 Hive Digital Technologies HIVE 24. avr 2025 2.39 +1.70   
 HLS Therapeutics Inc HLS 24. avr 2025 4.17 -0.95   
 Homeland Nickel Inc. SHL 24. avr 2025 0.06 0.00   
 Homeland Uranium Corp. HLU 24. avr 2025 0.25 0.00   
 Homerun Resources Inc HMR 24. avr 2025 1.05 +7.65   
 Honey Badger Silver Inc. TUF 24. avr 2025 0.11 +4.76   
 Horizn ActCdnMunBd E HMP 24. avr 2025 9.71 0.00   
 Horizn EURO STOX50 A HXX 24. avr 2025 56.90 +1.19   
 Horizn S&P500CA Hegd HSH 24. avr 2025 67.02 +1.67   
 Horizn S&PCapEngyIdx HXE 24. avr 2025 33.28 +0.88   
 Horizn S&PCapFin Idx HXF 24. avr 2025 83.09 +0.50   
 Horizn US7-10TreasBd HTB 24. avr 2025 58.73 +0.27   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.